Hualan Biological Vaccine (SZSE:301207) ROCE % : 17.68% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Hualan Biological Vaccine ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hualan Biological Vaccine's annualized ROCE % for the quarter that ended in Dec. 2023 was 17.68%.

Hualan Biological Vaccine ROCE % Historical Data

The historical data trend for Hualan Biological Vaccine's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Vaccine ROCE % Chart

Hualan Biological Vaccine Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

48.27

62.58

28.50

14.31

17.10

Hualan Biological Vaccine Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial														1.14	7.68	1.44	42.14	17.68

Hualan Biological Vaccine ROCE % Calculation

Hualan Biological Vaccine's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	1012.964	/	( ( (7075.517 - 1536.874)	+	(7995.318 - 1685.583) )	/ 2 )
	=	1012.964	/	( (5538.643	+	6309.735)	/ 2 )
	=	1012.964	/	5924.189
	=	17.10 %

Hualan Biological Vaccine's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	1094.612	/	( ( (7807.869 - 1733.667)	+	(7995.318 - 1685.583) )	/ 2 )
	=	1094.612	/	( ( 6074.202	+	6309.735 )	/ 2 )
	=	1094.612	/	6191.9685
	=	17.68 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Hualan Biological Vaccine (SZSE:301207) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hualan Biological Vaccine ROCE % Related Terms

Thank you for viewing the detailed overview of Hualan Biological Vaccine's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hualan Biological Vaccine (SZSE:301207) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Vaccine Inc (SZSE:301207) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003

Website

Hualan Biological Vaccine Inc is engaged in Research, development, production and sales of human vaccines.

Hualan Biological Vaccine (SZSE:301207) Headlines

No Headlines